- 24 h
- 7 Tage
- 14 Tage
- 6 Monate
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23:42 | VolitionRx offers oncology assets for licensing | 1 | Investing.com | ||
| 23:30 | GT Biopharma announces officer role change | 2 | Investing.com | ||
| 23:27 | Glucotrack, Inc. - S-1, General form for registration of securities | 2 | SEC Filings | ||
| 23:22 | GT Biopharma meldet Veränderung in der Führungsriege | 2 | Investing.com Deutsch | ||
| 23:12 | Augmedix, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 22:54 | PAVmed moves to deconsolidate Lucid Diagnostics | 1 | Investing.com | ||
| 22:54 | Agilon Health CEO Steven Sell buys $67k in company stock | 1 | Investing.com | ||
| 22:47 | How to stream using a VPN on Roku | 1 | Engadget | ||
| 22:46 | PAVmed leitet Entkonsolidierung von Lucid Diagnostics ein | 1 | Investing.com Deutsch | ||
| 22:30 | SUMMERSET GROUP HOLDINGS LIMITED: DRP Strike Price and AUD FX Rate for 2024 Interim Dividend | - | NZX | ||
| 22:30 | CareMax, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 22:19 | VOLITIONRX LTD - 8-K, Current Report | 1 | SEC Filings | ||
| 22:17 | HAEMONETICS CORP - 8-K, Current Report | 1 | SEC Filings | ||
| 22:15 | Venus Concept Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 22:14 | OWENS & MINOR INC/VA/ - 8-K, Current Report | 1 | SEC Filings | ||
| 22:06 | Soleno Therapeutics to Present at 2024 Cantor Global Healthcare Conference | 1 | GlobeNewswire (USA) | ||
| 22:05 | GT Biopharma, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 22:05 | PAVmed Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 22:01 | TechMediaBreaks - Owlet Inc. (NASDAQ: OWLT) Secures $46.6M in Public Offering and Debt Refinancing | 1 | iNVEZZ.com | ||
| 22:01 | Why Bausch + Lomb Rallied Today | 1 | The Motley Fool |
Seite:
1 2 3 4 5 Weiter >>
- 24 h
- 7 Tage
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | Aktuelle Nachrichten | |||
|---|---|---|---|---|---|---|---|
| GERRESHEIMER | 7 | 14 | -0,65 % | JEFFERIES stuft GERRESHEIMER AG auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Gerresheimer mit einem Kursziel von 121 Euro auf "Buy" belassen. Das Management des Pharma-Verpackungsherstellers strahle... ► Artikel lesen | ||
| MERIT MEDICAL SYSTEMS | 7 | 9 | +2,89 % | Key Takeaways From Merit Medical Systems Analyst Ratings | |||
| BAUSCH+LOMB | 7 | 9 | +14,29 % | Why Bausch + Lomb Rallied Today | |||
| ROKU | 5 | 14 | -1,48 % | How to stream using a VPN on Roku | |||
| INSPIREMD | 5 | 5 | +0,83 % | InspireMD, Inc.: InspireMD Announces Submission of Premarket Approval Application to FDA Seeking U.S. Regulatory Approval of the CGuard Prime Carotid Stent System | PMA based on overwhelmingly positive results from the pivotal C-GUARDIANS clinical study that were first presented at LINC 2024 in May U.S. commercial launch anticipated in H1 2025, if approved ... ► Artikel lesen | ||
| BRITANNIA LIFE SCIENCES | 4 | 4 | +90,00 % | XFRA L020: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | ||
| CARL ZEISS MEDITEC | 3 | 15 | +2,06 % | Carl Zeiss Meditec Aktie: Kursschwäche trotz positiver Prognosen | Die Carl Zeiss Meditec-Aktie erlebte am Donnerstag eine turbulente Handelssession an der XETRA-Börse. Eröffnet bei 58,80 EUR, schwankte der Kurs im Tagesverlauf zwischen 58,05 EUR und 58,95 EUR. Zum... ► Artikel lesen | ||
| SAFE GROUP | 3 | 4 | 0,00 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 13.09.2024 | Das Instrument B4Z AU000000BSE5 BASE RESOURCES LTD. EQUITY wird cum Kapitalmassnahme gehandelt am 13.09.2024 und ex Kapitalmassnahme am 16.09.2024 The instrument B4Z AU000000BSE5 BASE RESOURCES LTD.... ► Artikel lesen | ||
| LANTHEUS | 3 | 4 | +0,52 % | Lantheus Holdings, Inc.: Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024 | Study met its primary endpoint, demonstrating significant improvement in radiographic progression-free survival Overall Response Rate was 38.1% vs. 12.0% for the ARPI switch arm, including 9.3% Complete... ► Artikel lesen | ||
| GT BIOPHARMA | 3 | 3 | +0,46 % | GT Biopharma announces officer role change |
- Alle
| Unternehmen / Aktien | Aktueller Kurs | Ø Kursziel (Euro) | Potential (Euro) | kaufen | halten | verkaufen | |||
|---|---|---|---|---|---|---|---|---|---|
| ECKERT & ZIEGLER SE | 41,200 | 63,50 | +54 % | 5 | - | - | |||
| DRAEGERWERK AG & CO KGAA | 45,100 | 60,33 | +34 % | 5 | 2 | 2 | |||
| GERRESHEIMER AG | 99,75 | 129,11 | +29 % | 19 | - | - | |||
| CARL ZEISS MEDITEC AG | 57,00 | 69,71 | +22 % | 6 | 10 | 7 | |||
| SIEMENS HEALTHINEERS AG | 49,410 | 59,74 | +21 % | 18 | 4 | - | |||
| FRESENIUS SE & CO KGAA | 34,040 | 40,37 | +19 % | 13 | 4 | - | |||
| STRATEC SE | 40,950 | 44,25 | +8 % | 1 | 6 | - | |||
| FRESENIUS MEDICAL CARE AG | 37,260 | 37,43 | +0 % | 7 | 9 | 8 | |||
| ESSILORLUXOTTICA SA | 208,80 | 208,50 | 0 % | 12 | 7 | - |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
